Clinical Trial Update: A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a treatment for Primary vitreoretinal lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreoretinal Lymphoma

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Primary Vitreoretinal Lymphoma | Phase 3 | Status: RECRUITING